Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Obesity

methylprednisolone hemisuccinate has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Agati, VD; Markowitz, GS; Tartini, A1
Camara, DS; Dunn, TE; Jusko, WJ; Ludwig, EA; Slaughter, RL1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and Obesity

ArticleYear
Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity.
    Clinical pharmacology and therapeutics, 1991, Volume: 49, Issue:5

    Topics: Adult; Basophils; Circadian Rhythm; Drug Evaluation; Histamine; Humans; Hydrocortisone; Leukocyte Count; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Obesity; Regression Analysis; T-Lymphocytes, Helper-Inducer

1991

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Obesity

ArticleYear
Acute interstitial nephritis following treatment with anorectic agents phentermine and phendimetrazine.
    Clinical nephrology, 1998, Volume: 50, Issue:4

    Topics: Acute Disease; Anti-Inflammatory Agents; Appetite Depressants; Creatinine; Female; Follow-Up Studies; Glucocorticoids; Humans; Leukocytes; Methylprednisolone Hemisuccinate; Middle Aged; Morpholines; Nephritis, Interstitial; Obesity; Phentermine; Prednisone; Urine

1998